Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.

For many women with early breast cancer, surgery is effective but life-altering. New five-year data from the National ...

The Preston Robert Tisch Brain Tumor Center grants first IRB approval for APTN-101’s Phase I clinical trial, enabling patient recruitment to ...

Childhood cancer treatments can accelerate biological aging, increasing risks for long-term health issues like heart disease and hypertension. Epigenetic age acceleration measures the difference ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

KUWAIT CITY, Jan 17: Minister of Health Dr. Ahmad Al-Awadhi announced on Saturday that the Ministry has updated its treatment ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

Boundless persevered with the other drug, a CHK1 inhibitor BBI-355, as a monotherapy for oncogene-amplified solid tumors. But the clinical data showed signs of hematological toxicity that would have ...

After being described in 2018, researchers knew they had something interesting with T3p, a single small RNA found in breast ...

Updated NCCN Clinical Practice Guidelines in Oncology now recognize that MammaPrint and BluePrint testing can help identify a ...

The company is building a differentiated oncology pipeline supported by experienced leadership and scientific expertise ...